Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Joel Ackerman Net Worth & Insider Trades

Joel Ackerman - Director, Champions Oncology, Inc

As of November 7, 2023

What is Joel Ackerman's Net Worth?

The current estimated net worth of Champions Oncology, Inc's Director, Joel Ackerman, is estimated to be about $18.46M . Joel Ackerman owns about 1,021,731 units of Champions Oncology, Inc common stock. In the last 13 years at Champions Oncology, Inc, Joel Ackerman has sold an estimated value of $593.55K worth.

What is Joel Ackerman's Past Insider Trading?

Joel Ackerman's largest purchase order was 528,315 units , worth over $250K on January 30, 2013. Joel Ackerman's largest sale order was 22,535 units , worth over $383.55K on October 3, 2018. In total, Joel Ackerman has made about 26 transactions over 13 years of their time at Champions Oncology, Inc. Joel Ackerman usually trades in November, with the busiest year in 2016.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Joel Ackerman

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Joel Ackerman's' Mailing Address?

  • Mailing address is Coventry Health Care, Inc. 6705 Rockledge Dr Suite 900 Bethesda MD 20817 MD

What are Champions Oncology, Inc's Past Insider Trades?

Champions Oncology, Inc's most recent insider trade came on October 16, 2023 by Daniel Mendelson who bought 4,000 units worth $24.64K . In the last 19 years, insiders at Champions Oncology, Inc have sold an estimated value of $13.2M and bought an estimated value of $24.43M worth of shares. Insider trading is most common in November, with the busiest year in 2023. The most active traders at the company are Daniel Mendelson, Director,  Joel Ackerman, Director,  and Ronnie Morris, CEO .

CHAMPIONS ONCOLOGY, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...